Advanced Mesothelin (MSLN) Expressing Cancer

People with Advanced Mesothelin (MSLN) Expressing Cancer are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least ≥ 18 years of age
• Have adequate organ function
• Have MSLN- Expressing Cancer
• Have at least one measurable lesion
• Have advanced metastatic or unresectable cancer

You may not participate in this study if you:

• Have received cytotoxic chemotherapy within 3 weeks of leukapheresis
• Have had any previous allogeneic hematopoietic stem cell transplant
• Have central nervous system (CNS) disease/brain metastases
• Have a history of autoimmune or immune mediated disease
• Have any other prior or concurrent malignancy
• Have had any previous gene therapy
• Have had major surgery within 4 weeks
• Have clinically significant cardiac disease
• Have received COVID-19 vaccine within 4 weeks
• Are known to be positive for human immunodeficiency virus (HIV), hepatitis B, or C
• Are pregnant, breast feeding or planning to become pregnant

Contact Information
Aradhika Dhawan, Study Coordinator
111 E. 210th Street Bronx, NY 10467
Phone: (646) 918-0428